Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ARO-MUC5AC / Arrowhead
NCT05292950 / 2022-003467-21: Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease	Active, not recruiting	1	78	Europe, RoW	ARO-MUC5AC, Placebo	Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals, Inc.	Asthma, Chronic Obstructive Pulmonary Disease	11/24	11/24